High incidence and prevalence of HIV-1 infection in high risk population in Calcutta, India

International Journal of STD and AIDS

Volumn 14, Issue 7, 2003, Pages 463-468

  Gupta, Phalguni ^a,e   Kingsley, Lawrence ^a   Sheppard, Haynes W ^b   Harrison, Lee H ^a   Chatterjee, Ramdas ^c   Ghosh, Adhir ^d   Roy, Pratima ^d   Neogi, Dhruba K ^d  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

^c Chittaranjan National Cancer Research Institute and Hospital   (India)

^d CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

HIV 1; Incidence; India; Prevalence

Indexed keywords

ARTICLE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INDIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; WESTERN BLOTTING;

CONDOMS; EDUCATIONAL STATUS; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HIV-1; HUMANS; INCIDENCE; INDIA; LOGISTIC MODELS; MALE; MARITAL STATUS; MULTIVARIATE ANALYSIS; RESIDENCE CHARACTERISTICS; RISK FACTORS; SEXUAL BEHAVIOR;

EID: 0038005948     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646203322025768     Document Type: Article

References (23)

1. UNAIDS and WHO. HIV/AIDS: The global epidemic. UNAIDS Report, 1998
2. Anand K, Pandav CS, Nath LM. Impact of HIV/AIDS on the national economy of India. Health Policy 1999;47:195-205
3. Rubsamen-Waigmann H, Maniar JK, von Briesen H, et al. Spread of HIV-2 in India. Lancet 1991;337:550-1
4. Pfutzner A, Dietrich U, Von Eichel U, et al. HIV-1 and HIV-2 infections in a high-risk population in Bombay, India: Evidence for the spread of HIV-2 and the presence of a divergent HIV-1 subtype. J AIDS 1992;5:972-7
5. Grez M, Dietrich U, Balfe P, et al. Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses. J Virol 1992;68:2161-8
6. Bollinger RC, Tripathy SP, Quinn TC. The human immunodeficiency virus epidemic in India: Current magnitude and future projections. Medicine 1995;74:97-106
7. Mehendale SM, Rodrigues JJ, Brookmeyer RS, et al. Incidence and predictors of human immunodeficiency virus type 1 seroconversion in patients attending sexually transmitted disease clinics in India. J Infect Dis 1995;172:1486-91
8. John TJ, Keusch GT. Epidemiology of HIV and AIDS in India. AIDS 1994;8(Suppl 2):S61-75
9. Bollinger RC, Mehendale S, Gangakhedkar R, et al. HIN transmission in India: HIVNET update. Conf Adv AIDS Vac Dev 11-15 Feb 1996:221
10. Panda S, Wang G, Sarkar S, et al. Characterization of V3 loop of HIV type 1 spreading rapidly among injection drug users of Manipur, India: a molecular epidemiological perspective. AIDS Res Human Retrovir 1996;12:1571-3
11. Chakraborty S, Panda S, Chatterjee A, et al. HIV-1 subtypes in injecting drug users and their non-injecting wives in Manipur, India. Indian J Med Res 2000;111:189-94
12. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical prevention purposes. JAMA 1998;280:42-8
13. McRae B, Lange JMA, Ascher MS, et al. Immune response to HIVp24 core protein during the early phases of human immunodeficiency virus infection. AIDS Res Hum Retrovir 1991;7:637-43
14. Busch MP, Satten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med 1997;102:117-24
15. Cooper DA, Imrie AA, Penny R. Antibody response to human immunodeficiency virus after primary infection. J Infect Dis 1987;155:1113-18
16. Lange JMA, Parry JV, de Wolf F, et al. Diagnostic value of specific IgM antibodies in primary HIV infection. AIDS 1988;2:31-5
17. McDougal JS, Kennedy MS, Nicholson JKA, et al. Antibody response to human immunodeficiency virus in homosexual men. J Clin Invest 1987;80:316-24
18. Diaz RS, Kallas EG, Castello A, et al. Use of a new less-sensitive enzyme immunoassay testing strategy to identify recently infected persons in a Brazilian prison: estimation of incidence and epidemiological tracing. AIDS 1999;13:1417-18
19. Schechter M, do Lago RF, de Melo MF, et al. Identification of a high-risk heterosexual population for HIV prevention trials in Rio de Janeiro, Brazil. Projecto Praco Onze Study Group. J AIDS 2000;24:175-7
20. McFarland W, Busch MP, Kellogg TA, et al. Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San Francisco. J AIDS 1999;15:484-9
21. Shankarappa R, Chatterjee R, Learn GH, et al. Human immunodeficiency virus type 1 env sequences from Calcutta in Eastern India: Identification of features that distinguish subtype C sequences in India from other subtype C sequences. J Virol 2001;75:10479-87
22. Brookmeyer R, Quinn T, Shepherd M, et al. The AIDS epidemic in India: A new method for estimating current HIV incidence rates. Am J Epidemiol 1995;142:709-13
23. Sheppard HW, Ascher MS, McRae B, et al. The initial immune response to HIV and immune system activation determine the outcome of HIV disease. J Acquir Immune Defic Syndr 1991;4:704-12